ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

US News

Frequency Electronics talk 2015 results

Mar 11 2015 @ 15:10
How did they do? Frequency Electronics, Inc. (Nasdaq:FEIM) reported revenues for the third quarter of fiscal 2015, which ended January 31, 2015, of $18.4 million, compared to $18.2 million recorded in the third quarter of fiscal 2014. Revenues for the first nine months of fiscal 2015 were $57.4 million compared to $52.1 million recorded in […]
 

Cartesian increases European operations

Mar 11 2015 @ 15:07
What are they up to? Cartesian (Nasdaq:CRTN), a specialist provider of consulting services and managed solutions to the global communications, technology and digital media industries, today announced the expansion of its business development team in the European market with the addition of three new hires. Andy Harper, Andy Weston and Jonathan Hayley join Cartesian’s EMEA […]
 

Strat Aero raises £660k to capitalise on new opportunities

Mar 11 2015 @ 14:59
Raises £660,000 to Capitalise on New Opportunities in the Unmanned Aerial Vehicle Sector Strat Aero plc, an international aerospace services company, has raised £660,000, before expenses, through the issue of 7,333,334 new ordinary shares at 9p per share. This funding marks a significant step for Strat Aero as it continues to realise its strategy of […]
 

Changes at the top for Northcote in Mexico

Mar 11 2015 @ 14:55
Appointment of Executive Vice President – Mexico Northcote (LSE:NCT), an onshore US oil and gas exploration and production company, has said that Mr. Abraham Achar has joined the Company as full time Executive Vice President – Mexico. In this role, Mr. Achar will lead and develop business development activities in Mexico, which has recently reopened […]
 

Manic-Depressive Markets

Mar 10 2015 @ 15:01
“Like any high-stakes business, the highs and lows can make you a manic-depressive person, if you weren’t that way to start with.” Sounds like someone commenting on the stock market – and anyone involved with it – doesn’t it? One day everyone is euphoric. The next, they are ready to admit themselves to the nearest […]
 

Northcote Energy cut deal to drill new conventional well at Shoats Creek

Mar 10 2015 @ 14:47
New Shoats Creek Well Update Northcote (LSE:NCT) has announced that it is has been informed by Aminex USA Inc., the Operator of Shoats Creek, that it has signed a rig contract to drill a new conventional vertical well at Shoats Creek Field. Highlights: · The new well, the Lutcher Moore #20, has been prepared and […]
 

Rose Petroleum talks Utah operations

Mar 09 2015 @ 16:29
Operations update Rose Petroleum, the AIM-listed (LSE:ROSE) natural resources company, has provided an operational update on activities within its US onshore oil and gas division which is made up of a 75% working interest in over 250,000 gross acres in the highly prospective Uinta and Paradox Basins in Utah. Highlights: State 1-34 Mancos Well, Uinta […]
 

McDonalds Leaving a Bad Taste

Mar 09 2015 @ 14:08
Perhaps it would be in McDonalds’ (NYSE:MCD) best interest to stop publishing their monthly results until their operational results turn around. February 2015 results just extended the continuum of disappointment for another 30 days (I know. February has only 28 days, but that’s not the point.) McDonalds’ share price is currently at 97.94, up only […]
 

Emergent BioSolutions detail 2014 results and 2015 plans

Mar 05 2015 @ 17:10
Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and twelve months ended December 31, 2014. Financial highlights included: – Total revenue: Q4 2014 of $148.0 million, up 51% from 2013; twelve months 2014 of $450.1 million, up 44% from 2013 – GAAP net income: Q4 2014 of $30.1 million, up 98% from 2013; […]
 

Calithera Biosciences cuts new deal with TransTech Pharma

Mar 05 2015 @ 17:07
For TransTech Pharma’s Hexokinase II Inhibitor Program Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, announced today an exclusive global license agreement with TransTech Pharma, a clinical stage...
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com